Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Journal of Periodontal Research, 2026

Proteomic Characterization of Grade II Furcation Defects: A Discovery‐Phase Study

Chatzopoulos G., Sakellari D., Kaklamanos E. et al.

Hypertension, 2026

Integrative Proteomic Profiling of Blood Pressure and Hypertension

Aggarwal M., Joehanes R., Huan T. et al.

Translational Psychiatry, 2026

Astrocyte-related proteins mediate the association of YWHAG with Alzheimer’s pathology and enhance its diagnostic value

Zhang Z., Huang P., Yang Y. et al.

Lipids in Health and Disease, 2026

Significant correlations between blood lipids, cytokines, and C-reactive protein in healthy humans

Larsson A., Eriksson L., Eriksson M.

Journal of Investigative Dermatology, 2026

Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls

Sacknovitz Y., Zhou M., Kent J. et al.

Clinical Rheumatology, 2026

Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma

Wang H., Yan H., Yang M. et al.

Cardiovascular Research, 2026

miR-146a-5p mediates atherogenic signalling from immune to vascular cells

Climent M., Zani S., Salvarani N. et al.

HemaSphere, 2026

Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients

Diorio C., Myers R., Li Y. et al.

Metabolism, 2026

When the proteome meets the metabolome observational and Mendelian randomization analyses

Zheng R., Delgado-Velandia M., Ärnlöv J. et al.

CNS Neuroscience & Therapeutics, 2026

Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via CCR2 / NF ‐ κB ‐Mediated Blood–Brain Barrier Disruption

Huang R., Gao L., Dai Y. et al.

Open Forum Infectious Diseases, 2026

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV

Murthy A., Kolossváry M., Walpert A. et al.

Pulmonology, 2026

Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study

He L., Liu C., Zhao H. et al.

Circulation: Genomic and Precision Medicine, 2026

Associations of the ICAM1 p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome

Aneja A., Culler K., Ding J. et al.

Frontiers in Immunology, 2026

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia

Wang J., Pan S., Xiong C. et al.

Clinical & Experimental Allergy, 2026

Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

Sun N., Pat Y., Babayev H. et al.

British Journal of Cancer, 2026

Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer

Rahkola O., Tuomisto A., Elomaa H. et al.

Journal of Proteome Research, 2026

Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis

Chu X., Li Y., Wang F. et al.

Translational Psychiatry, 2026

Plasma proteome profiling identifies novel biomarkers and predictors for schizophrenia

Wu S., Guo X., Jia T. et al.

Aging Cell, 2026

Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease

Tavenier J., Holm N., Kallemose T. et al.

Medicine, 2026

Association of genetically determined plasma hepatocyte growth factor with lung cancer and its subtypes: Mendelian randomization and mediation analysis

Xu F., Xu Q., Yu J. et al.

4555 publications